Literature DB >> 9234071

Establishment and characterization of a new human glioblastoma cell line (MGM-1) with highly motile phenotype.

T Moriyama1, H Kataoka, K Seguchi, K Nabeshima, H Kawano, T Goya, S Wakisaka, A Ohgami, J Suzumiya, M Kikuchi, M Koono.   

Abstract

A new cell line MGM-1 was established from a primary tumor of the left temporal lobe with histological diagnosis of glioblastoma multiforme, removed from a 64-year-old Japanese male. The patient died of recurrence and unusual extracranial metastases of the tumor 7 months after the surgery. The cultured MGM-1 cells are spindle or polygonal in shape. After serial passages, glial fibrillary acidic protein became negative immunocytochemically in vitro. The modal chromosome number was 61-64. Doubling time and soft agar colony forming efficiency were 42.9h and 0.4%, respectively (at 25th passage). MGM-1 is a highly motile cell line in vitro and its serum-free conditioned medium is chemotactic and chemokinetic for other glioma cells. Secretion of gelatinases (probably MMP-2/72-kDa type i.v. collagenase) and MMP-9/92-kDa type i.v. collagenase) and urokinase-type plasminogen activator were also investigated. MGM-1 would therefore be useful for studying the mechanisms regulating glioma-cell motility and invasion. The MGM-1 cell line has been propagated continuously by serial passages (more than 100 passages) during the past 4 years.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234071

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  4 in total

1.  Establishment and characterization of human glioblastoma cell line (HUBT-n).

Authors:  Isamu Ishiwata; Chieko Ishiwata; Emiko Ishiwata; Megumi Iguchi; Yoshiro Sato; Makoto Sonobe; Kazushige Kiguchi; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

2.  Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma.

Authors:  Tsuyoshi Fukushima; Makiko Kawaguchi; Kenji Yorita; Hiroyuki Tanaka; Hideo Takeshima; Kazuo Umezawa; Hiroaki Kataoka
Journal:  Neuro Oncol       Date:  2011-10-03       Impact factor: 12.300

3.  Establishment and characterization of a new human glioblastoma cell line, NYGM.

Authors:  Yoshitsugu Nuki; Shunro Uchinokura; Shiro Miyata; Tsuyoshi Fukushima; Ryouichi Hamasuna; Shinichi Nakano; Shinichiro Wakisaka; Yutaka Akiyama; Hiroshi Itoh; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2004-09       Impact factor: 4.174

Review 4.  Bone metastasis from glioblastoma: a systematic review.

Authors:  Michael J Strong; Sravanthi Koduri; Jodi A Allison; Cecilia M Pesavento; Sebele Ogunsola; Oludotun Ogunsola; Timothy J Yee; Siri Sahib S Khalsa; Yamaan S Saadeh; Jacob R Joseph; Osama N Kashlan; Paul Park; Mark E Oppenlander; Nicholas J Szerlip
Journal:  J Neurooncol       Date:  2022-05-17       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.